Clinical Trials Directory

Trials / Completed

CompletedNCT02410824

Bilateral Dispensing Clinical Trial of Stenfilcon A Against Etafilcon A for Astigmatism

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
52 (actual)
Sponsor
CooperVision, Inc. · Industry
Sex
All
Age
17 Years
Healthy volunteers
Not accepted

Summary

Bilateral dispensing clinical trial of stenfilcon A against etafilcon A for astigmatism.

Detailed description

CooperVision is evaluating the clinical performance of an FDA cleared silicone-hydrogel lens material stenfilcon A (test) compared to etafilcon A for Astigmatism lens (control) when worn on a daily wear basis over one (1) week in a randomized, bilateral, cross-over, dispensing study.

Conditions

Interventions

TypeNameDescription
DEVICEstenfilcon A toric lenstoric contact lens
DEVICEetafilcon A toric lenstoric contact lens

Timeline

Start date
2015-04-01
Primary completion
2015-06-01
Completion
2015-06-01
First posted
2015-04-08
Last updated
2017-08-21
Results posted
2017-03-08

Locations

2 sites across 2 countries: United States, Canada

Source: ClinicalTrials.gov record NCT02410824. Inclusion in this directory is not an endorsement.